210 related articles for article (PubMed ID: 29114736)
1. Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years.
Haaland GS; Falk RS; Straume O; Lorens JB
JAMA Intern Med; 2017 Dec; 177(12):1774-1780. PubMed ID: 29114736
[TBL] [Abstract][Full Text] [Related]
2. Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015.
Kjerpeseth LJ; Ellekjær H; Selmer R; Ariansen I; Furu K; Skovlund E
Eur J Clin Pharmacol; 2017 Nov; 73(11):1417-1425. PubMed ID: 28735494
[TBL] [Abstract][Full Text] [Related]
3. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
[TBL] [Abstract][Full Text] [Related]
4. Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation.
Lau WC; Chan EW; Cheung CL; Sing CW; Man KK; Lip GY; Siu CW; Lam JK; Lee AC; Wong IC
JAMA; 2017 Mar; 317(11):1151-1158. PubMed ID: 28324091
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice.
Frost L; Johnsen SP; Pedersen L; Toft E; Husted S; Sørensen HT
J Intern Med; 2002 Jul; 252(1):64-9. PubMed ID: 12074740
[TBL] [Abstract][Full Text] [Related]
7. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.
Halvorsen S; Ghanima W; Fride Tvete I; Hoxmark C; Falck P; Solli O; Jonasson C
Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):28-36. PubMed ID: 27680880
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
9. Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.
Chang SH; Chou IJ; Yeh YH; Chiou MJ; Wen MS; Kuo CT; See LC; Kuo CF
JAMA; 2017 Oct; 318(13):1250-1259. PubMed ID: 28973247
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
Larsen TB; Rasmussen LH; Skjøth F; Due KM; Callréus T; Rosenzweig M; Lip GY
J Am Coll Cardiol; 2013 Jun; 61(22):2264-73. PubMed ID: 23562920
[TBL] [Abstract][Full Text] [Related]
11. Association Between Use of Antithrombotic Medication and Hematuria-Related Complications.
Wallis CJD; Juvet T; Lee Y; Matta R; Herschorn S; Kodama R; Kulkarni GS; Satkunasivam R; Geerts W; McLeod A; Narod SA; Nam RK
JAMA; 2017 Oct; 318(13):1260-1271. PubMed ID: 28973248
[TBL] [Abstract][Full Text] [Related]
12. Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients.
Andersson T; Magnuson A; Bryngelsson IL; Frøbert O; Henriksson KM; Edvardsson N; Poçi D
PLoS One; 2017; 12(5):e0176846. PubMed ID: 28472091
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation.
Avgil Tsadok M; Jackevicius CA; Rahme E; Humphries KH; Behlouli H; Pilote L
JAMA; 2012 May; 307(18):1952-8. PubMed ID: 22570463
[TBL] [Abstract][Full Text] [Related]
15. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
[TBL] [Abstract][Full Text] [Related]
16. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
17. Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.
Ashburner JM; Go AS; Chang Y; Fang MC; Fredman L; Applebaum KM; Singer DE
J Am Geriatr Soc; 2017 Jan; 65(1):35-41. PubMed ID: 27861698
[TBL] [Abstract][Full Text] [Related]
18. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
19. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.
Fang MC; Go AS; Hylek EM; Chang Y; Henault LE; Jensvold NG; Singer DE
J Am Geriatr Soc; 2006 Aug; 54(8):1231-6. PubMed ID: 16913990
[TBL] [Abstract][Full Text] [Related]
20. Prescription Patterns of Non-Vitamin K Oral Anticoagulants Across Indications and Factors Associated with Their Increased Prescribing in Atrial Fibrillation Between 2012-2015: A Study from the Norwegian Prescription Database.
Urbaniak AM; Strøm BO; Krontveit R; Svanqvist KH
Drugs Aging; 2017 Aug; 34(8):635-645. PubMed ID: 28710707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
